Bhi Nausea Tablet
FDA Label NDC 62795-1004

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Bhi Nausea (NDC 62795-1004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding inactive ingredients, purpose, uses, directions, warnings, keep out of reach of children, active ingredient, bhi nausea tablet, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Inactive Ingredients

Lactose and Magnesium stearate

Purpose

Nausea Relief Tablets

Relieves:

• Nausea

• Vomiting

• Indigestion

Uses

For the temporary relief of minor nausea, vomiting, indigestion

Directions

At first sign of symptoms:Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.

Standard dosage: Adults and children 4 years and older: 3 tablets per day, taking 1 tablet every 4 to 6 hours.

For children under 4, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow

Warnings

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to BHI Nausea or any of its ingredients exists.

Keep Out Of Reach Of Children

Keep out of reach of children

Active Ingredient

Each tablet contains: *Anacardium orientale 6X, Argentum nitricum 8X, *Carbo vegetabilis 12X, *Ipecacuanha 6X, *Iodium 12X, *Robinia pseudoacacia 10X, *Sepia 30X 42.9 mg each.

*Natural Ingredients

* Please review the disclaimer below.